{"id":1093,"date":"2026-07-14T08:19:18","date_gmt":"2026-07-14T06:19:18","guid":{"rendered":"https:\/\/infoimasd.com\/?p=1093"},"modified":"2026-07-14T08:19:19","modified_gmt":"2026-07-14T06:19:19","slug":"criteriacaixa-300-millones-startups-criteria-capital-risc","status":"publish","type":"post","link":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/","title":{"rendered":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica"},"content":{"rendered":"\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>CriteriaCaixa ha acordado impulsar su actividad inversora en <a href=\"https:\/\/infoimasd.com\/index.php\/2026\/06\/26\/evaluacion-ley-startups-espana-ecosistema-emprendedor\/\" data-type=\"post\" data-id=\"851\">startups<\/a> para facilitar el crecimiento de compa\u00f1\u00edas emergentes de base cient\u00edfica y tecnol\u00f3gica con alto potencial. <\/strong>El objetivo cuantificado es <strong>alcanzar un volumen de inversi\u00f3n de 300 millones de euros<\/strong> en empresas innovadoras en fases iniciales de su actividad. Lo har\u00e1 a trav\u00e9s de sus dos fondos especializados: Criteria Bio Ventures, orientado a biotecnolog\u00eda y ciencias de la vida, y Criteria Venture Tech, centrado en tecnolog\u00eda.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">CriteriaCaixa busca <strong>impulsar terapias y tecnolog\u00edas transformadoras que puedan tener un impacto positivo en la sociedad,<\/strong> priorizando la creaci\u00f3n de valor a largo plazo. Un planteamiento que combina retorno financiero con vocaci\u00f3n de impacto, en l\u00ednea con la naturaleza de CriteriaCaixa como brazo inversor de la Fundaci\u00f3 la Caixa.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>Las inversiones se centrar\u00e1n prioritariamente en Espa\u00f1a y Portugal,<\/strong> mercados en los que CriteriaCaixa ya tiene una presencia consolidada. De forma selectiva, el foco se extender\u00e1 tambi\u00e9n a Europa y Norteam\u00e9rica. Actualmente, cerca del 70% del valor de la cartera corresponde a inversiones realizadas en Espa\u00f1a, lo que refleja el sesgo dom\u00e9stico de la estrategia y su potencial de internacionalizaci\u00f3n progresiva.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">El contexto: un ecosistema que demanda m\u00e1s capital en fases tempranas<\/h3>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">La decisi\u00f3n de CriteriaCaixa llega en un momento en que el ecosistema espa\u00f1ol de startups crece con fuerza. Ya hay m\u00e1s de <a href=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/09\/spain-global-startuphub-2026-icex-ecosistema-emprendedor\/\" data-type=\"post\" data-id=\"1029\">5.000 compa\u00f1\u00edas activas con casi 15.000 millones de facturaci\u00f3n en 2025.<\/a> Sin embargo, <strong>el ecosistema sigue adoleciendo de la escasez de capital paciente y de largo plazo en las fases m\u00e1s tempranas. <\/strong>Algo que ocurre especialmente en sectores intensivos en I+D como la biotecnolog\u00eda o las deeptech. Con 300 millones comprometidos y dos fondos especializados por sector, CriteriaCaixa refuerza su posici\u00f3n como uno de los pocos inversores institucionales espa\u00f1oles con capacidad para acompa\u00f1ar ese tipo de compa\u00f1\u00edas desde sus estadios m\u00e1s tempranos hasta la escala.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Caixa Capital Risc se convierte en Criteria Capital Risc<\/h3>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">El anuncio de la ampliaci\u00f3n inversora viene acompa\u00f1ado de un cambio de marca relevante. En el marco del Plan Estrat\u00e9gico 2030, CriteriaCaixa ha acordado cambiar el nombre de la gestora de venture capital que administra ambos fondos para adaptarla a la realidad actual de la compa\u00f1\u00eda. <strong>Caixa Capital Risc, nacida en 2002 en el seno de la Caixa y filial 100% de CriteriaCaixa desde 2013, pasa a operar bajo la nueva denominaci\u00f3n Criteria Capital Risc.<\/strong> El cambio no altera la estructura societaria ni la titularidad, sino que unifica la identidad de la gestora con la marca corporativa del grupo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El brazo inversor de la Fundaci\u00f3 la Caixa refuerza su apuesta por empresas emergentes en Espa\u00f1a, Portugal y, de forma selectiva, Europa y Norteam\u00e9rica. Caixa Capital Risc pasa a llamarse Criteria Capital Risc dentro del Plan Estrat\u00e9gico 2030.<\/p>\n","protected":false},"author":1,"featured_media":1094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[10,93],"tags":[379,429,430,115,406],"class_list":["post-1093","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financiacion","category-mundo-empresarial","tag-biotecnologia","tag-criteria-capital-risc","tag-criteriacaixa","tag-startups","tag-venture-capital"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica - INFO I+D<\/title>\n<meta name=\"description\" content=\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica a trav\u00e9s de Criteria Bio Ventures y Criteria Venture Tech.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica - INFO I+D\" \/>\n<meta property=\"og:description\" content=\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica a trav\u00e9s de Criteria Bio Ventures y Criteria Venture Tech.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/\" \/>\n<meta property=\"og:site_name\" content=\"INFO I+D\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-14T06:19:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-14T06:19:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Miguel Guti\u00e9rrez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Miguel Guti\u00e9rrez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/\"},\"author\":{\"name\":\"Miguel Guti\u00e9rrez\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/person\\\/7d19b1faaeac5b8ab56fbdb8f46fc85e\"},\"headline\":\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica\",\"datePublished\":\"2026-07-14T06:19:18+00:00\",\"dateModified\":\"2026-07-14T06:19:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/\"},\"wordCount\":449,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Portada-CriteriaCaixa.png\",\"keywords\":[\"Biotecnolog\u00eda\",\"Criteria Capital Risc\",\"CriteriaCaixa\",\"Startups\",\"venture capital\"],\"articleSection\":[\"Financiaci\u00f3n\",\"Mundo Empresarial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/\",\"name\":\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica - INFO I+D\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Portada-CriteriaCaixa.png\",\"datePublished\":\"2026-07-14T06:19:18+00:00\",\"dateModified\":\"2026-07-14T06:19:19+00:00\",\"description\":\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica a trav\u00e9s de Criteria Bio Ventures y Criteria Venture Tech.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Portada-CriteriaCaixa.png\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Portada-CriteriaCaixa.png\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/2026\\\/07\\\/14\\\/criteriacaixa-300-millones-startups-criteria-capital-risc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/infoimasd.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#website\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/\",\"name\":\"infoimasd.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/infoimasd.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#organization\",\"name\":\"INFO I+D\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-INFO-ID-RELIEVE-150-X-150.png\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-INFO-ID-RELIEVE-150-X-150.png\",\"width\":1254,\"height\":1254,\"caption\":\"INFO I+D\"},\"image\":{\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/#\\\/schema\\\/person\\\/7d19b1faaeac5b8ab56fbdb8f46fc85e\",\"name\":\"Miguel Guti\u00e9rrez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860\",\"url\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860\",\"contentUrl\":\"https:\\\/\\\/infoimasd.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860\",\"caption\":\"Miguel Guti\u00e9rrez\"},\"description\":\"Director de INFO I+D\",\"sameAs\":[\"https:\\\/\\\/infoimasd.com\\\/\"],\"url\":\"https:\\\/\\\/infoimasd.com\\\/index.php\\\/author\\\/admin8536\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica - INFO I+D","description":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica a trav\u00e9s de Criteria Bio Ventures y Criteria Venture Tech.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/","og_locale":"es_ES","og_type":"article","og_title":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica - INFO I+D","og_description":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica a trav\u00e9s de Criteria Bio Ventures y Criteria Venture Tech.","og_url":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/","og_site_name":"INFO I+D","article_published_time":"2026-07-14T06:19:18+00:00","article_modified_time":"2026-07-14T06:19:19+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png","type":"image\/png"}],"author":"Miguel Guti\u00e9rrez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Miguel Guti\u00e9rrez","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#article","isPartOf":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/"},"author":{"name":"Miguel Guti\u00e9rrez","@id":"https:\/\/infoimasd.com\/#\/schema\/person\/7d19b1faaeac5b8ab56fbdb8f46fc85e"},"headline":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica","datePublished":"2026-07-14T06:19:18+00:00","dateModified":"2026-07-14T06:19:19+00:00","mainEntityOfPage":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/"},"wordCount":449,"commentCount":0,"publisher":{"@id":"https:\/\/infoimasd.com\/#organization"},"image":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#primaryimage"},"thumbnailUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png","keywords":["Biotecnolog\u00eda","Criteria Capital Risc","CriteriaCaixa","Startups","venture capital"],"articleSection":["Financiaci\u00f3n","Mundo Empresarial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/","url":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/","name":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica - INFO I+D","isPartOf":{"@id":"https:\/\/infoimasd.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#primaryimage"},"image":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#primaryimage"},"thumbnailUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png","datePublished":"2026-07-14T06:19:18+00:00","dateModified":"2026-07-14T06:19:19+00:00","description":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica a trav\u00e9s de Criteria Bio Ventures y Criteria Venture Tech.","breadcrumb":{"@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#primaryimage","url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png","contentUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/infoimasd.com\/index.php\/2026\/07\/14\/criteriacaixa-300-millones-startups-criteria-capital-risc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infoimasd.com\/"},{"@type":"ListItem","position":2,"name":"CriteriaCaixa destinar\u00e1 300 millones a startups de base cient\u00edfica y tecnol\u00f3gica"}]},{"@type":"WebSite","@id":"https:\/\/infoimasd.com\/#website","url":"https:\/\/infoimasd.com\/","name":"infoimasd.com","description":"","publisher":{"@id":"https:\/\/infoimasd.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infoimasd.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/infoimasd.com\/#organization","name":"INFO I+D","url":"https:\/\/infoimasd.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/#\/schema\/logo\/image\/","url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/05\/Logo-INFO-ID-RELIEVE-150-X-150.png","contentUrl":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/05\/Logo-INFO-ID-RELIEVE-150-X-150.png","width":1254,"height":1254,"caption":"INFO I+D"},"image":{"@id":"https:\/\/infoimasd.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infoimasd.com\/#\/schema\/person\/7d19b1faaeac5b8ab56fbdb8f46fc85e","name":"Miguel Guti\u00e9rrez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860","url":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860","contentUrl":"https:\/\/infoimasd.com\/wp-content\/litespeed\/avatar\/8bbe81d383fcd5d10975c32a324d8b3d.jpg?ver=1790012860","caption":"Miguel Guti\u00e9rrez"},"description":"Director de INFO I+D","sameAs":["https:\/\/infoimasd.com\/"],"url":"https:\/\/infoimasd.com\/index.php\/author\/admin8536\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/infoimasd.com\/wp-content\/uploads\/2026\/07\/Portada-CriteriaCaixa.png","_links":{"self":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/1093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/comments?post=1093"}],"version-history":[{"count":1,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/1093\/revisions"}],"predecessor-version":[{"id":1095,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/posts\/1093\/revisions\/1095"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/media\/1094"}],"wp:attachment":[{"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/media?parent=1093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/categories?post=1093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infoimasd.com\/index.php\/wp-json\/wp\/v2\/tags?post=1093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}